Trial Profile
A Prospective Study of Higher Neural Control Changes Following Intradetrusor Injection of BotulinumtoxinA in Patients With Multiple Sclerosis and Lower Urinary Tract Symptoms.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Neurogenic bladder
- Focus Therapeutic Use
- 24 Mar 2020 Status changed from recruiting to completed.
- 09 Apr 2018 Status changed from active, no longer recruiting to recruiting.
- 03 Feb 2017 New trial record